Brooklyn ImmunoTherapeutics (BTX)
NASDAQ:BTX
US Market
Holding BTX?
Track your performance easily

Brooklyn ImmunoTherapeutics (BTX) Financial Statements

0 Followers

Brooklyn ImmunoTherapeutics Financial Overview

Brooklyn ImmunoTherapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Brooklyn ImmunoTherapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -3.38M$ -9.37M$ -8.44M$ -86.04M$ -10.01M
EBITDA$ -3.23M$ -9.24M$ -8.32M$ -85.91M$ -9.90M
Net Income Common Stockholders$ -3.41M$ -9.38M$ -8.47M$ -86.06M$ -10.09M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.41M$ 16.98M$ 19.41M$ 23.50M$ 24.38M
Total Assets$ 26.90M$ 35.38M$ 32.43M$ 39.39M$ 64.71M
Total Debt$ 1.17M$ 2.29M$ 2.72M$ 3.23M$ 3.36M
Net Debt$ -7.24M$ -14.69M$ -16.68M$ -20.27M$ -21.02M
Total Liabilities$ 12.12M$ 18.07M$ 25.93M$ 26.35M$ 29.53M
Stockholders Equity$ 6.50M$ 13.04M$ 14.78M$ 17.31M$ 35.18M
Cash Flow-
Free Cash Flow$ -4.18M$ -5.48M$ -6.98M$ -6.43M$ -6.80M
Operating Cash Flow$ -3.99M$ -5.43M$ -6.83M$ -6.42M$ -6.80M
Investing Cash Flow$ -87.00K$ -46.00K$ -147.39K$ -22.86M$ -466.00
Financing Cash Flow$ -13.00K$ 11.99M$ -418.62K$ 3.50M$ 48.56M
Currency in USD

Brooklyn ImmunoTherapeutics Earnings and Revenue History

Brooklyn ImmunoTherapeutics Debt to Assets

Brooklyn ImmunoTherapeutics Cash Flow

Brooklyn ImmunoTherapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis